gm-csf plasmid
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2008 (NCT00455221)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Granulocyte-macrophage colony-stimulating factorSupplementation
CSF2 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gm-csf plasmid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00669136 | Phase 1 | Jun 1, 2009 | National Cancer Institute (NCI), University of Pittsburgh |
| NCT00455221 | Phase 1 | Feb 1, 2008 | Isfahan University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Isfahan University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2009 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1